Skyward Specialty Insurance
SKWD
57.47
+0.98
+1.73%
Skyward Specialty Insurance
US · SKWD
#2644 by market cap
Listed 2023
57.47
+0.98
+1.73%
Live - 5344 symbols - heartbeat 258s ago
· 2026-10-08 07:58
Pre-market
57.47
0.00%
After-hours
57.47
0.00%
- Market cap
- 2.55B
- P/E (TTM)i
- 13.37
- P/Bi
- 2.01
- EPSi
- 4.07
- Div yieldi
- 0.00%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on SKWD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 0.3 percentage points.
Institutional ownership
- Held by institutions
- 91.15% +0.33pp
- Institutions
- 288
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund83.57%
Individual/Insider8.59%
Hedge Fund3.61%
Public Company1.62%
Government Pension Fund1.16%
Private Company0.53%
Family Office/Trust0.36%
Sovereign Wealth Fund0.16%
Insurance Company0.14%
Other0.27%
Top holders as of 2026-06-30
BlackRock
8.28% · 3.68M sh
Reinhart Partners, LLC
6.52% · 2.89M sh
James Hays
6.35% · 2.82M sh
T. Rowe Price Group, Inc.
6.07% · 2.70M sh
Invesco Ltd.
4.51% · 2.00M sh
Vanguard Capital Management, LLC
4.29% · 1.90M sh
Columbia Management Investment Advisers, LLC
3.63% · 1.61M sh
Westwood Management Corp.
2.87% · 1.27M sh
American Century Investment Management
2.77% · 1.23M sh
State Street Global Advisors
2.63% · 1.17M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| James Hays | Independent Director | 6.35% |
| David Ben Ibeson | -- | 0.78% |
| Andrew Robinson | Chief Executive Officer | 0.41% |
| Mark Haushill | Chief Financial Officer | 0.31% |
| James Slaughter | -- | 0.15% |
| Robert Creager | Independent Director | 0.12% |
| John Burkhart | Executive VP & President of Specialty Lines | 0.09% |
| Daniel Paul Bodnar | Chief Information & Technology Officer | 0.06% |
| Leslie Shaunty | General Counsel | 0.06% |
| Sean Duffy | Executive VP & Chief Claims Officer | 0.05% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-05 | Peter Hearn | Independent Director | Other Derivative Acquisition | +1,845 | -- |
| 2026-06-11 | Thomas Schmitt | Chief People & Administrative Officer | Open Market Disposition | -8,397 | $51.32 |
| 2026-06-11 | Thomas Schmitt | Chief People & Administrative Officer | Intent to Sell (Form 144) | -8,397 | -- |
| 2026-05-20 | Anthony Kuczinski | Director | Open Market Acquisition | +2,000 | $47.00–47.20 |
| 2026-05-10 | Gena Ashe | Independent Director | Intent to Sell (Form 144) | -740 | -- |
| 2026-05-10 | Gena Ashe | Independent Director | Derivative Exercise and Sale | -740 | $46.35 |
| 2026-05-10 | Gena Ashe | Independent Director | Derivative Exercise and Retained | +1,057 | -- |
| 2026-05-06 | Anthony Kuczinski | Director | Derivative Exercise and Retained | +1,797 | -- |
| 2026-05-05 | Michael Morrissey | Director | Other Derivative Acquisition | +3,334 | -- |
| 2026-05-05 | Anthony Kuczinski | Director | Other Derivative Acquisition | +3,334 | -- |
| 2026-05-05 | Mark Haushill | Chief Financial Officer | Derivative Exercise and Sale | -1,982 | $43.68 |
| 2026-05-05 | Mark Haushill | Chief Financial Officer | Derivative Exercise and Retained | +3,054 | -- |
| 2026-05-05 | Marcia Dall | Independent Director | Other Derivative Acquisition | +3,334 | -- |
| 2026-05-05 | Andrew Robinson | Chief Executive Officer | Derivative Exercise and Sale | -7,930 | $43.68 |
| 2026-05-05 | Andrew Robinson | Chief Executive Officer | Derivative Exercise and Retained | +12,220 | -- |
| 2026-05-05 | Christopher Peirce | Director | Other Derivative Acquisition | +3,890 | -- |
| 2026-05-05 | Gena Ashe | Independent Director | Other Derivative Acquisition | +3,334 | -- |
| 2026-05-05 | John Burkhart | Executive VP & President of Specialty Lines | Derivative Exercise and Sale | -1,894 | $43.68 |
| 2026-05-05 | John Burkhart | Executive VP & President of Specialty Lines | Derivative Exercise and Retained | +2,919 | -- |
| 2026-05-05 | Sean Duffy | Executive VP & Chief Claims Officer | Derivative Exercise and Sale | -1,671 | $43.68 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:58:37 · For reference only, not investment advice and not tailored to your situation.